High-grade ovarian cancer associated H/ACA snoRNAs promote cancer cell proliferation and survival. Issue 1 (14th January 2022)

• Record Type: Journal Article
• Authors: Faucher-Giguère, Laurence; Roy, Audrey; Deschamps-Francoeur, Gabrielle; Couture, Sonia; Nottingham, Ryan M; Lambowitz, Alan M; Scott, Michelle S; Abou Elela, Sherif
• Is Part Of: NAR cancer. Volumer 4:Issue 1(2022)
• Publication Date: 2022-01-14
• Subjects: Cancer -- Periodicals; Cancer -- Genetic aspects -- Periodicals; Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 616.994
• DOI: 10.1093/narcan/zcab050
• Languages: English
• ISSNs: 2632-8674

Abstract

ABSTRACT: Small nucleolar RNAs (snoRNAs) are an omnipresent class of non-coding RNAs involved in the modification and processing of ribosomal RNA (rRNA). As snoRNAs are required for ribosome production, the increase of which is a hallmark of cancer development, their expression would be expected to increase in proliferating cancer cells. However, assessing the nature and extent of snoRNAs' contribution to cancer biology has been largely limited by difficulties in detecting highly structured RNA. In this study, we used a dedicated midsize non-coding RNA (mncRNA) sensitive sequencing technique to accurately survey the snoRNA abundance in independently verified high-grade serous ovarian carcinoma (HGSC) and serous borderline tumour (SBT) tissues. The results identified SNORA81, SNORA19 and SNORA56 as an H/ACA snoRNA signature capable of discriminating between independent sets of HGSC, SBT and normal tissues. The expression of the signature SNORA81 correlates with the level of ribosomal RNA (rRNA) modification and its knockdown inhibits 28S rRNA pseudouridylation and accumulation leading to reduced cell proliferation and migration. Together our data indicate that specific subsets of H/ACA snoRNAs may promote tumour aggressiveness by inducing rRNA modification and synthesis. GRAPHICAL ABSTRACT: